Quiz|Articles|July 3, 2025
Dermatology Times Spot Test: July 3, 2025
Author(s)Emma Andrus, Editor
Listen
0:00 / 0:00
Key Takeaways
- Chronic hand eczema significantly impacts patients' quality of life, especially in work-related scenarios, necessitating effective management strategies.
- Recent studies underscore the emotional burden of CHE, highlighting the importance of addressing psychological aspects in treatment plans.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Dermatology Times presents: Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology.
This week, we’ll focus on news, updates, and research in
Do you have a set of quiz questions to share? Contact editor Emma Andrus at
What is the primary benefit of early and aggressive therapy in the management of CHE?
According to recent findings, what factor is commonly associated with a significant emotional burden in patients with work-related CHE?
What is the major limitation of routine patch testing in the diagnosis of CHE?
References
- Mense SA, Maher S, Chovatiya R. A practical approach to chronic hand eczema. Dermatol Ther (Heidelb). 2025;15(7):1953-1971. doi:10.1007/s13555-025-01433-y
- Rocholl M, Brans R, Wilke A, Meyer J, John SM, Ludewig M. Emotional burden of patients with work-related hand eczema: results of an exploratory study in a tertiary individual prevention setting in Germany. Contact Dermatitis. Published online June 1, 2025. doi:10.1111/cod.14819
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
